K. Hählen

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

Bianca F. Goemans, Ch. M. Zwaan, Mitchell Miller et al. · Leukemia · 2005 · 240 citations · Full text

Medicine, Genetics, Oncology +12

In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions

Rob Pieters, AH Loonen, DR Huismans et al. · Blood · 1990 · 231 citations · Full text

Medicine, Oncology, Pharmacology +8

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia

E. Klumper, Rob Pieters, DR Huismans et al. · Blood · 1995 · 218 citations · Full text

Medicine, Pediatrics, Pharmacology +14

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.

K. Hählen, Willem A. Kamps, E. F. van Leeuwen et al. · Journal of Clinical Oncology · 1996 · 208 citations

Medicine, Oncology, Pediatrics +17

Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples

Jacqueline Cloos, Bianca F. Goemans, Corine J. Hess et al. · Leukemia · 2006 · 178 citations

Medicine, Molecular Genetics, Oncology +14